Zidesamtinib in ROS1-positive NSCLC with brain metastases: clinical evidence and therapeutic implications

Abdihakim Sheikh S. Saleem S. B. Imran Ehtisham Haider

Sep 2026 · Annals of Medicine and Surgery · Vol 88, pp. 6924 - 6925 · 0 citations · 5 references

Medicine

Abstract

rearrangements are a unique molecular subset of non-small cell lung cancer (NSCLC),

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.